UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients—Authors´ Reply

The Lancet regional health. Europe, 2021-11, Vol.10, p.100244-100244, Article 100244

2021

Volltextzugriff (PDF)

Ferroptosis and Necroptosis in the Kidney

Cell chemical biology, 2020-04, Vol.27 (4), p.448-462

2020

Volltextzugriff (PDF)

Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type

Frontiers in medicine, 2022-07, Vol.9, p.910987-910987

2022

Volltextzugriff (PDF)

The scar that never felt a wound

Kidney international, 2020-03, Vol.97 (3), p.460-462

2020

Volltextzugriff (PDF)

KTeXpand – a novel microfluidic device for advanced cell based cross matching

Current directions in biomedical engineering, 2022-09, Vol.8 (2), p.501-504

2022

Volltextzugriff (PDF)

MMF/MPA Is the Main Mediator of a Delayed Humoral Response With Reduced Antibody Decline in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination

Frontiers in medicine, 2022-07, Vol.9, p.928542-928542

2022

Volltextzugriff (PDF)

A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse

Kidney international, 2021-11, Vol.100 (5), p.1135-1136

2021

Volltextzugriff (PDF)

Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis

Proceedings of the National Academy of Sciences - PNAS, 2019-10, Vol.116 (44), p.22269-22274

2019

Volltextzugriff (PDF)

4233 FIXED LOW DOSE VERSUS CONCENTRATION-CONTROLLED INITIAL TACROLIMUS DOSING: RESULTS FROM A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL (SLOW&LOW STUDY)

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and hemodialysis patients using mRNA vaccines

Nephrology, dialysis, transplantation, 2021-11

2021

Volltextzugriff (PDF)

vPIF-1 is an insulin-like antiferroptotic viral peptide

Proceedings of the National Academy of Sciences - PNAS, 2023-05, Vol.120 (21), p.e2300320120-e2300320120

2023

Volltextzugriff (PDF)

Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines

Nephrology, dialysis, transplantation, 2022-03, Vol.37 (4), p.796-798

2022

Volltextzugriff (PDF)

Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients

Journal of clinical virology, 2023-05, Vol.162, p.105428-105428, Article 105428

2023

Volltextzugriff (PDF)

3973 EXCELLENT EFFICACY AND BENEFICIAL SAFETY DURING FIVE YEAR FOLLOW-UP OF RAPID STEROID WITHDRAWAL AFTER RENAL TRANSPLANTATION (HARMONY STUDY)

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

New automatic quantification method of immunofluorescence and histochemistry in whole histological sections

Cellular signalling, 2019-10, Vol.62, p.109335-109335, Article 109335

2019

Volltextzugriff (PDF)

Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow & Low study)

EClinicalMedicine, 2024-01, Vol.67, p.102381-102381, Article 102381

2024

Volltextzugriff (PDF)

Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study

The Lancet regional health. Europe, 2022-06, Vol.17, p.100371-100371, Article 100371

2022

Volltextzugriff (PDF)

The Impact of Transfusion-Dependency on the Outcome of Patients with Myelodysplastic Syndromes (MDS) Receiving Allogeneic Peripheral Blood Stem Cell Transplantation after Myeloablative Conditioning

Blood, 2007-11, Vol.110 (11), p.1467-1467

2007

Volltextzugriff (PDF)

Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)

Biology of blood and marrow transplantation, 2008-11, Vol.14 (11), p.1217-1225

2008

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients—Authors´ Reply

Ferroptosis and Necroptosis in the Kidney

Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type

The scar that never felt a wound

KTeXpand – a novel microfluidic device for advanced cell based cross matching

MMF/MPA Is the Main Mediator of a Delayed Humoral Response With Reduced Antibody Decline in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination

Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc Study

A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse

Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis

4233 FIXED LOW DOSE VERSUS CONCENTRATION-CONTROLLED INITIAL TACROLIMUS DOSING: RESULTS FROM A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL (SLOW&LOW STUDY)

Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and hemodialysis patients using mRNA vaccines

vPIF-1 is an insulin-like antiferroptotic viral peptide

Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines

Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients

3973 EXCELLENT EFFICACY AND BENEFICIAL SAFETY DURING FIVE YEAR FOLLOW-UP OF RAPID STEROID WITHDRAWAL AFTER RENAL TRANSPLANTATION (HARMONY STUDY)

New automatic quantification method of immunofluorescence and histochemistry in whole histological sections

9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients

5687 SARS-COV-2 PREEXPOSURE PROTECTS FROM IMMUNITY-FADING AFTER MRNA VACCINATION IN KIDNEY TRANSPLANT RECIPIENTS, DIALYSIS PATIENTS, AND MEDICAL PERSONNEL

5093 DIALYSIS PATIENTS AND BNT162B2MRNA VACCINE TYPE ARE RISK FACTORS FOR IMMUNITY FADING 9 MONTHS AFTER SARS-COV-2MRNA VACCINATION (DIA-VACC STUDY)

Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow & Low study)

Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow Low study)Research in context

Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch Methods

Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study

The Impact of Transfusion-Dependency on the Outcome of Patients with Myelodysplastic Syndromes (MDS) Receiving Allogeneic Peripheral Blood Stem Cell Transplantation after Myeloablative Conditioning

Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)

Suchergebnisse filtern